INAN, M. Et Al. 2007. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.34 , 457-461.

INAN, M., BASARAN, U., DOKMECI, D., KANTER, M., YALCIN, O., Aydogdu, N., ... TURAN, N.(2007). Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.34, 457-461.

INAN, Mustafa Et Al. "Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats," CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.34, 457-461, 2007

INAN, Mustafa Et Al. "Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.34, pp.457-461, 2007

INAN, M. Et Al. (2007) . "Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.34, pp.457-461.

@article{article, author={Mustafa INAN Et Al. }, title={Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats}, journal={CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY}, year=2007, pages={457-461} }